DEPO : Summary for Depomed, Inc. - Yahoo Finance

U.S. Markets open in 4 hrs 56 mins

Depomed, Inc. (DEPO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.77-0.70 (-4.25%)
At close: 4:00PM EST
People also watch
HZNPDRRXDVAXCYTKAMAG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close16.47
Open16.31
Bid16.06 x 400
Ask16.99 x 200
Day's Range15.64 - 16.60
52 Week Range12.25 - 27.02
Volume3,335,837
Avg. Volume1,504,034
Market Cap971.13M
Beta1.47
PE Ratio (TTM)-12.82
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com8 hours ago

    Depomed Reports 33% Increase in 2016 Net Product Sales

    While companies in the opiod sector have had to deal with headlines about abuse as well as pharma pricing controversies, Depomed reported increased sales across its product line.

  • Associated Press12 hours ago

    Depomed reports 4Q loss

    On a per-share basis, the Newark, California-based company said it had a loss of 72 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to 48 cents per share. The results topped ...

  • GlobeNewswire13 hours ago

    Depomed Reports Fourth Quarter and Full Year 2016 Financial Results

    -Record Annual Revenue of $456 million in 2016-. -Record Quarterly Revenue of $124 million in Fourth Quarter–. -Conference Call Scheduled for Today at 4:30 PM EST; Dial-In Information Below-.